The estimated value of insider holdings of NOVARTIS AG is at least $1,149,370,768 dollars as of 28 Oct 2025. NOVARTIS AG is the 10%+ Owner of Tourmaline Bio, Inc. and owns shares of Tourmaline Bio, Inc. (TRML) stock worth about $1.15B.
There are no insider transactions reported by NOVARTIS AG
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.